The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 104.00
Bid: 102.00
Ask: 106.00
Change: -1.50 (-1.42%)
Spread: 4.00 (3.922%)
Open: 105.50
High: 105.50
Low: 104.00
Prev. Close: 105.50
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of CFO

12 Apr 2022 07:00

RNS Number : 0270I
Intercede Group PLC
12 April 2022
 

12 April 2022

Intercede Group plc

 

("Intercede" or the "Company")

 

Appointment of CFO

 

Intercede, the leading specialist in digital identity, credential management and secure mobility, is pleased to announce the appointment of Nitil Patel as Chief Financial Officer with effect from 19 April 2022.

 

Mr Patel is a Fellow of the Institute of Chartered Accountants in England & Wales and has over 25 years' financial experience in both industry and public practice. He most recently held the position of interim CFO at D4t4 Solutions plc, a technology leader in data platforms and prior to that he was CFO of Merit Group plc. Between 2001 and 2016, Nitil was CFO of Zinc Media Group plc. He has extensive financial, commercial, M&A and business transformation experience.

 

As announced on 23 November 2021, Andrew Walker will remain with Intercede as a Director until June to ensure a smooth transition through the year end audit.

 

Intercede CEO Klaas van der Leest said:

"We are delighted to announce Nitil's appointment as CFO. He brings plc board experience, and his strong commercial acumen will be of great value as we look to execute our growth plans."

 

 

ENQUIRIES

 

Intercede Group plc

Tel. +44 (0)1455 558 111

Klaas van der Leest, Chief Executive

finnCap

Tel. + 44 (0)20 7220 0500

Simon Hicks / Fergus Sullivan, Corporate Finance

Tim Redfern / Charlotte Sutcliffe, ECM

 

Regulatory disclosures

 

The following information regarding Nitil Patel, aged 51, is disclosed under Schedule 2(g) of the AIM Rules for Companies:

 

Current Directorships

Directorships held in past 5 years

 

Opendemocracy Limited

Dods Group Limited

The Opendemocracy Foundation for the Advancement of Global Education

Doreen Bird College Of Performing Arts Ltd.

The Doreen Bird Foundation

Fenman Limited

Holyrood Communications Ltd.

Merit Data & Technology Limited

Merit Group Plc

Merit Processes Limited

Mislex (420) Limited

Monitoring Services Limited

Political Wizard Limited

Social Lens Limited

Soma21 Limited

Syntri Group Limited

Syntri Limited

Syntri Media Group Limited

Total Politics Limited

Training Journal Limited

Vacher Dod Publishing Limited

Vdp Limited

 

 

Mr. Patel was previously a director of Ten Alps Media Limited, a subsidiary of Ten Alps plc, which, in the 12 months after Mr Patel had resigned from the company, announced that it had instructed professionals to place the subsidiary into a creditors' voluntary liquidation. There was estimated to be a deficit to preferential creditors of approximately £14,323.62 and an estimated deficit to unsecured creditors of £710,502.

 

There are no other matters which are required to be announced under Schedule 2(g) of the AIM Rules for Companies.

 

 

About Intercede

Intercede is a cybersecurity company specialising in digital identities, derived credentials and access control, enabling digital trust in a mobile world.

 

Headquartered in the UK, with offices in the US, we believe in a connected world in which people and technology are free to exchange information securely, and complex insecure passwords become a thing of the past.

 

Our vision is to make the highest levels of cybersecurity available to organizations and consumers alike, solving complexity and scalability issues by managing high volumes of digital credentials.

 

We have been delivering trusted solutions to high profile customers for over 20 years. Our team of experts has deployed millions of identities to governments, most of the largest aerospace and defence corporations, and major financial services and healthcare organizations, as well as leading telecommunications, cloud services and information technology firms, providing industry-leading employee and customer credential management systems.

For more information visit: www.intercede.com

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZGMDVMVGZZM
Date   Source Headline
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report
7th Nov 20237:00 amRNSContract and Renewals Orders
25th Oct 20234:44 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSNotice of Interim Results & Investor Presentation
20th Oct 20237:03 amRNSAppointment of Non-Executive Director
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSTrading Update
21st Sep 20231:31 pmRNSResult of AGM
4th Sep 20237:00 amRNSContract and Renewals Orders
30th Aug 20237:10 amRNSNotice of AGM and Publication of Annual Report
20th Jun 20237:01 amRNSBoard Changes
20th Jun 20237:00 amRNSFinal Results
12th Jun 20237:00 amRNSNotice of Results & Investor Presentation
27th Apr 20237:00 amRNSShare Incentive Plan
17th Apr 20237:00 amRNSTrading Update
3rd Apr 20237:00 amRNSContract wins/renewals
3rd Feb 202310:46 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSChange of Auditors
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20232:00 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSTrading Update
11th Jan 20232:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20228:45 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSHalf-year Report
11th Nov 20227:00 amRNSNotice of Interim Results & Investor Presentation
13th Oct 202210:30 amRNSDirector/PDMR Shareholding
11th Oct 20221:00 pmRNSDirector/PDMR Shareholding
10th Oct 20228:00 amRNSLong Term Incentive Plan
10th Oct 20227:01 amRNSAcquisition of Authlogics Ltd
10th Oct 20227:00 amRNSTrading Update
28th Sep 202212:22 pmRNSResult of AGM
15th Sep 20227:00 amRNSDirector/PDMR Shareholding and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.